Our Mission is to develop and commercialize transdermal pharmaceuticals that have either greater efficacy, an improved safety profile, or increased patient compliance.
- To learn more about EstroGel, the first transdermal gel for estrogen therapy, visit our web site at www.estrogel.com
- To learn more about Prochieve® 4% (progesterone gel)—an FDA-approved, bioidentical, vaginal progesterone product indicated for the treatment of secondary amenorrhea—visit the product website at www.prochieve4.com
- To learn more about Migranal® (dihydroergotamine mesylate)—an FDA-approved intranasal treatment for migraine headache sufferers, the majority of whom are women—visit the product website at www.migranal.com